Vir (Biotechnology) Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 444
Employees
  • Stock Symbol
  • VIR
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $22.47
  • (As of Monday Closing)

Vir (Biotechnology) General Information

Description

Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.

Contact Information

Website
www.vir.bio
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 499 Illinois Street
  • Suite 500
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vir (Biotechnology) Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.47 $23.20 $22.08 - $68.20 $3.07B 132M 1.51M $4.07

Vir (Biotechnology) Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 4,612,660 4,612,660 2,600,676 1,695,613
Revenue 1,095,415 1,095,415 76,368 8,091
EBITDA 555,174 555,174 (296,005) (178,523)
Net Income 528,584 528,584 (298,665) (174,683)
Total Assets 1,954,268 1,954,268 918,761 512,071
Total Debt 137,488 137,488 70,181 237
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vir (Biotechnology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vir (Biotechnology)‘s full profile, request access.

Request a free trial

Vir (Biotechnology) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Vir (Biotechnology)‘s full profile, request access.

Request a free trial

Vir (Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. I
Drug Discovery
San Francisco, CA
444 As of 2021
00000
000000 - 000 00000

00000000

sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000

00000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
0000 000000000
Gaithersburg, MD
00 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vir (Biotechnology) Competitors (85)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000000 Corporate Backed or Acquired Gaithersburg, MD 00 000.00 000000 - 000 000.00
0000000 Venture Capital-Backed Saint-Herblain, France 000 00000 0000000000 00000
0000000 0000000000 Formerly VC-backed Basel, Switzerland 000 00000 0000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 85 competitors. Get the full list »

Vir (Biotechnology) Patents

  • 20

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 5

    Pending

  • 000

    Expiring in next 12 mo

Vir (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210261650-A1 Antibodies against sars-cov-2 and methods of using the same Pending 26-Feb-2020 000000000
EP-3872091-A1 Antibodies against sars-cov-2 and methods of using the same Pending 26-Feb-2020 000000000 00
AU-2020276243-A1 Compositions and methods for treating hepatitis b virus (hbv) infection Pending 13-May-2019 00000000000
AU-2020266283-A1 Antibodies binding to plasmodium circumsporozoite protein and uses thereof Pending 30-Apr-2019 000000000
CA-3130805-A1 Antibodies binding to plasmodium circumsporozoite protein and uses thereof Pending 30-Apr-2019 A61K38/03
To view Vir (Biotechnology)’s complete patent history, request access »

Vir (Biotechnology) Executive Team (20)

Name Title Board Seat Contact Info
George Scangos Ph.D Chief Executive Officer, President & Board Member
Howard Horn Chief Financial Officer
Steven Rice Chief Administrative Officer, Administration
Alex Bangs Chief Information Officer
Herbert Virgin Ph.D Chief Scientific Officer & Executive Vice President
You’re viewing 5 of 20 executive team members. Get the full list »

Vir (Biotechnology) Board Members (14)

Name Representing Role Since
Dipchand Nishar Self Board Member 000 0000
Elliott Sigal Vir (Biotechnology) Board Member 000 0000
George Scangos Ph.D Vir (Biotechnology) Chief Executive Officer, President & Board Member 000 0000
Janet Napolitano Vir (Biotechnology) Board Member 000 0000
Jeffrey Hatfield Vir (Biotechnology) Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Vir (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vir (Biotechnology) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vir (Biotechnology)‘s full profile, request access.

Request a free trial

Vir (Biotechnology) Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 09-May-2018 0000000000 Biotechnology
000000 000000 25-Sep-2017 0000000000 Other Pharmaceuticals and Biotechnology 000 00000
TomegaVax 06-Jan-2017 Merger/Acquisition Drug Discovery 000000 00
To view Vir (Biotechnology)’s complete acquisitions history, request access »

Vir (Biotechnology) Subsidiaries (1)

Company Name Industry Location Founded
000000 000000 Other Pharmaceuticals and Biotechnology Bellinzona, Switzerland 0000
To view Vir (Biotechnology)’s complete subsidiaries history, request access »

Vir (Biotechnology) Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 06-Jan-2017 000000000000000000 Completed
  • 000 (0000000000000
To view Vir (Biotechnology)’s complete exits history, request access »